Want to join the conversation?
$KMI's BoD approved an increase in its quarterly cash dividend to $0.51 per share, payable on Nov. 13 to shareholders of record as on Nov. 2. This represented a 16% rise over 3Q14 of $0.44 and is up from $0.49 for 2Q15. This is $KMI's 15th quarterly dividend since it went public in Feb. 2011.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.